all report title image
  • Published On : Jun 2020
  • Code : CMI365
  • Industry : Medical Devices
  • Pages : 180
  • Formats :
Ingographics Image

Contraceptive drugs and devices that aid to control birth rate and unintended pregnancies are subject to unique regulatory challenges across different countries. For instance, contraceptive drugs and devices face reimbursement challenges in the U.S., while contraceptive pills face advertising restrictions in India. Owing to this, contraceptives preference greatly various across countries. Statistics revealed by the United Nations in 2015, highlight this trends, with a particular contraceptive accounting for over 50% share across 45 countries considered in the study. Sterilization is a dominant contraceptive method in regions such as Asia, North America, and Latin America as per the study.

Restraints of the Global Contraceptives Market

Major factors hampering the growth of the contraceptives market during the forecast period constitutes of side effects associated with drugs and devices, and low adoption of emergency contraceptives in emerging economies.

Key features of the study:

  • This report provides in-depth analysis of the global contraceptives market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global contraceptives market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Evofem Biosciences, Inc., Actavis Generics (Teva Pharmaceutical Industries Ltd.), Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Uniprix, Gavis Pharmaceuticals (Lupin Limited), Sandoz International GmbH, Aurobindo Pharma Limited, HRA Pharma, SA, Mankind Pharma, Merck & Co, Bayer HealthCare AG, Church & Dwight, Co. Inc., Allergan, Pfizer, Inc., Agile Therapeutics Inc., BioSante Pharmaceuticals Inc., Mayer Laboratories, Inc., and Pantarhei Bioscience B.V.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global contraceptives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Contraceptives Market, By Type:
    • Drugs
      • Oral Contraceptive Pills
      • Injectables
      • Topical
    • Devices
      • Male Condoms
      • Female Condoms
      • Diaphragms
      • Sponges
      • Vaginal Rings
      • Subdermal Implants
      • IUD
  • Global Contraceptives Market, By Geography:
    • North America
      • By Type
        • Drugs
          • Oral Contraceptive Pills
          • Injectables
          • Topical
        • Devices
          • Male Condoms
          • Female Condoms
          • Diaphragms
          • Sponges
          • Vaginal Rings
          • Subdermal Implants
          • IUD
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Type
        • Drugs
          • Oral Contraceptive Pills
          • Injectables
          • Topical
        • Devices
          • Male Condoms
          • Female Condoms
          • Diaphragms
          • Sponges
          • Vaginal Rings
          • Subdermal Implants
          • IUD
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type
        • Drugs
          • Oral Contraceptive Pills
          • Injectables
          • Topical
        • Devices
          • Male Condoms
          • Female Condoms
          • Diaphragms
          • Sponges
          • Vaginal Rings
          • Subdermal Implants
          • IUD
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Type
        • Drugs
          • Oral Contraceptive Pills
          • Injectables
          • Topical
        • Devices
          • Male Condoms
          • Female Condoms
          • Diaphragms
          • Sponges
          • Vaginal Rings
          • Subdermal Implants
          • IUD
    • Middle East:
      • By Type
        • Drugs
          • Oral Contraceptive Pills
          • Injectables
          • Topical
        • Devices
          • Male Condoms
          • Female Condoms
          • Diaphragms
          • Sponges
          • Vaginal Rings
          • Subdermal Implants
          • IUD
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Type
        • Drugs
          • Oral Contraceptive Pills
          • Injectables
          • Topical
        • Devices
          • Male Condoms
          • Female Condoms
          • Diaphragms
          • Sponges
          • Vaginal Rings
          • Subdermal Implants
          • IUD
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Evofem Biosciences, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Actavis Generics (Teva Pharmaceutical Industries Ltd.)
    • Sun Pharmaceutical Industries Ltd.
    • Perrigo Company plc
    • Uniprix
    • Gavis Pharmaceuticals (Lupin Limited)
    • Sandoz International GmbH
    • Aurobindo Pharma Limited
    • HRA Pharma
    • Mankind Pharma
    • Other Major Players

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario
  4. Global Contraceptives Market, By Type, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • Oral Contraceptive Pills
        • Injectables
        • Topical
    • Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • Male Condoms
        • Female Condoms
        • Diaphragms
        • Sponges
        • Vaginal Rings
        • Subdermal Implants
        • IUD
  5. Global Contraceptives Market, By Regions, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  6. Competitive Landscape
    • Company Profiles
      • Evofem Biosciences, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Actavis Generics (Teva Pharmaceutical Industries Ltd.)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sun Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Perrigo Company plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Uniprix
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Gavis Pharmaceuticals (Lupin Limited)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sandoz International GmbH
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Aurobindo Pharma Limited
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • HRA Pharma
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Mankind Pharma
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Other Major Players
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 27 figures on “Contraceptives Market – Global forecast to 2027.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo